CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy

Bray Denard, Sharon Jiang, Yan Peng, Jin Ye

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint Dive into the research topics of 'CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences